Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schmidt-Wolf

Showing results (31-40 of 71) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|July 1, 1994
Propagation of large numbers of T cells with natural killer cell markersI G Schmidt-Wolf, P Lefterova, V Johnston, et al.
Cancer Gene Therapy|July 1, 1997
Increase of cytotoxic sensitivity of primary human melanoma cells transfected with the interleukin-7 gene to autologous and allogeneic immunologic effector cellsS Finke, B Trojaneck, P Möller, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2000
Targeting of natural killer-like T immunologic effector cells against leukemia and lymphoma cells by reverse antibody-dependent cellular cytotoxicityP Lefterova, A Märten, P Buttgereit, et al.
Blood|February 1, 1991
Use of the polymerase chain reaction to monitor the effectiveness of ex vivo tumor cell purgingR S Negrin, H P Kiem, I G Schmidt-Wolf, et al.
British Journal of Haematology|July 1, 1995
Propagation of large numbers of cells of a human mixed-lineage T-lymphoid/myeloidI G Schmidt-Wolf, B Grimm, P Lefterova, et al.
The Journal of Experimental Medicine|July 1, 1991
Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activityI G Schmidt-Wolf, R S Negrin, H P Kiem, et al.
Acta Haematologica|January 13, 2001
Increased sensitivity of myeloid leukemia cell lines: potential of lovastatin as bone-marrow-purging agentC Scheffold, B Schöttker, P Lefterova, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2000
Increase of the immunostimulatory effect of dendritic cells by pulsing with CA 19-9 proteinA Märten, B Schöttker, C Ziske, et al.
Deutsche Medizinische Wochenschrift (1946)|December 5, 2013
[Evaluation of 12 pilot projects to improve outpatient palliative care]G Schmidt-Wolf, F Elsner, G Lindena, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 10, 2000
Establishment and characterization of colon carcinoma and renal cell carcinoma primary culturesB Trojaneck, S Niemitz, B Micka, et al.
Pageof 8

Showing results (31-40 of 71) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|July 1, 1994
Propagation of large numbers of T cells with natural killer cell markersI G Schmidt-Wolf, P Lefterova, V Johnston, et al.
Cancer Gene Therapy|July 1, 1997
Increase of cytotoxic sensitivity of primary human melanoma cells transfected with the interleukin-7 gene to autologous and allogeneic immunologic effector cellsS Finke, B Trojaneck, P Möller, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2000
Targeting of natural killer-like T immunologic effector cells against leukemia and lymphoma cells by reverse antibody-dependent cellular cytotoxicityP Lefterova, A Märten, P Buttgereit, et al.
Blood|February 1, 1991
Use of the polymerase chain reaction to monitor the effectiveness of ex vivo tumor cell purgingR S Negrin, H P Kiem, I G Schmidt-Wolf, et al.
British Journal of Haematology|July 1, 1995
Propagation of large numbers of cells of a human mixed-lineage T-lymphoid/myeloidI G Schmidt-Wolf, B Grimm, P Lefterova, et al.
The Journal of Experimental Medicine|July 1, 1991
Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activityI G Schmidt-Wolf, R S Negrin, H P Kiem, et al.
Acta Haematologica|January 13, 2001
Increased sensitivity of myeloid leukemia cell lines: potential of lovastatin as bone-marrow-purging agentC Scheffold, B Schöttker, P Lefterova, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 5, 2000
Increase of the immunostimulatory effect of dendritic cells by pulsing with CA 19-9 proteinA Märten, B Schöttker, C Ziske, et al.
Deutsche Medizinische Wochenschrift (1946)|December 5, 2013
[Evaluation of 12 pilot projects to improve outpatient palliative care]G Schmidt-Wolf, F Elsner, G Lindena, et al.
Cancer Biotherapy & Radiopharmaceuticals|May 10, 2000
Establishment and characterization of colon carcinoma and renal cell carcinoma primary culturesB Trojaneck, S Niemitz, B Micka, et al.
Pageof 8